Patient safety β recording risks, consent, safety checks, and outcomes
Clinical governance β standardised records across all injection types
Contractual compliance β ensuring Local Enhanced Service (LES) activity is coded correctly
Audit and medico-legal protection
Generic Injection Template
For use with most routine injections where no condition-specific template applies.
Covers pre-procedure, administration, and post-procedure workflow.
Includes standard coding for injection events.
Condition-Specific Injection Templates
These build on the generic structure but include tailored fields for specific drugs or services:
B12 Injections β includes indication, loading vs maintenance course, symptoms, and blood test review
Methotrexate Injections β includes pre-dose checks (FBC, LFTs, U&Es, infection, pregnancy), folic acid cover, and toxicity counselling
Denosumab Injections β includes calcium/vitamin D status, renal function, and dental risk checks
Hormone Injections β includes indications (oncology, endometriosis), pregnancy status, side-effect counselling, and bone health monitoring
Neuroleptic Depot Injections β includes responsibility for care (practice vs CMHT), safety monitoring, site rotation, and recall management
Where a Local Enhanced Service exists, a dedicated section is automatically included at the top of the relevant template.
This ensures activity is coded correctly for claiming and audit.
You do not need to search for or open a separate LES template.
Pre-procedure β risks discussed, consent, 6 safety checks, cold chain (if relevant)
Administration β drug, dose, route, site, needle size, technique (e.g. Z-track, aseptic)
Post-procedure β immediate outcome, aftercare advice, sharps disposal, Yellow Card if required
Always use the condition-specific template when available β this ensures additional checks (e.g. methotrexate labs, denosumab dental health) are completed.
If no specific template exists, use the Generic Injection Template.
Document consent and risks consistently β protects both patient and clinician.
For ongoing therapies (e.g. depot injections), use recall/future action entries to support continuity.